BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 27599248)

  • 1. Lung cancer screening: latest developments and unanswered questions.
    van der Aalst CM; Ten Haaf K; de Koning HJ
    Lancet Respir Med; 2016 Sep; 4(9):749-761. PubMed ID: 27599248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lung cancer screening.
    Tanoue LT; Tanner NT; Gould MK; Silvestri GA
    Am J Respir Crit Care Med; 2015 Jan; 191(1):19-33. PubMed ID: 25369325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement.
    Moyer VA;
    Ann Intern Med; 2014 Mar; 160(5):330-8. PubMed ID: 24378917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lung Cancer Screening.
    Hoffman RM; Sanchez R
    Med Clin North Am; 2017 Jul; 101(4):769-785. PubMed ID: 28577626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cumulative incidence of false-positive test results in lung cancer screening: a randomized trial.
    Croswell JM; Baker SG; Marcus PM; Clapp JD; Kramer BS
    Ann Intern Med; 2010 Apr; 152(8):505-12, W176-80. PubMed ID: 20404381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The United States Preventive Services Task Force recommendations for lung cancer screening.
    Blackmon SH; Feinglass SR
    Thorac Surg Clin; 2015 May; 25(2):199-203. PubMed ID: 25901563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lung cancer risk by years since quitting in 30+ pack year smokers.
    Pinsky PF; Zhu CS; Kramer BS
    J Med Screen; 2015 Sep; 22(3):151-7. PubMed ID: 25926339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidental renal tumours on low-dose CT lung cancer screening exams.
    Pinsky PF; Dunn B; Gierada D; Nath PH; Munden R; Berland L; Kramer BS
    J Med Screen; 2017 Jun; 24(2):104-109. PubMed ID: 28482765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benefits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the U.S. Preventive Services Task Force.
    de Koning HJ; Meza R; Plevritis SK; ten Haaf K; Munshi VN; Jeon J; Erdogan SA; Kong CY; Han SS; van Rosmalen J; Choi SE; Pinsky PF; Berrington de Gonzalez A; Berg CD; Black WC; Tammemägi MC; Hazelton WD; Feuer EJ; McMahon PM
    Ann Intern Med; 2014 Mar; 160(5):311-20. PubMed ID: 24379002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for lung cancer: 2023 guideline update from the American Cancer Society.
    Wolf AMD; Oeffinger KC; Shih TY; Walter LC; Church TR; Fontham ETH; Elkin EB; Etzioni RD; Guerra CE; Perkins RB; Kondo KK; Kratzer TB; Manassaram-Baptiste D; Dahut WL; Smith RA
    CA Cancer J Clin; 2024; 74(1):50-81. PubMed ID: 37909877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lung cancer screening: the radiologist's perspective.
    Prokop M
    Semin Respir Crit Care Med; 2014 Feb; 35(1):91-8. PubMed ID: 24481763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effective use of low-dose computed tomography lung cancer screening.
    Jeffers CD; Pandey T; Jambhekar K; Meek M
    Curr Probl Diagn Radiol; 2013; 42(5):220-30. PubMed ID: 24070715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lung Cancer Screening.
    Choi HK; Mazzone PJ
    Med Clin North Am; 2022 Nov; 106(6):1041-1053. PubMed ID: 36280331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating efficacy of current lung cancer screening guidelines.
    Nemesure B; Plank A; Reagan L; Albano D; Reiter M; Bilfinger TV
    J Med Screen; 2017 Dec; 24(4):208-213. PubMed ID: 28201949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Applying the National Lung Screening Trial eligibility criteria to the US population: what percent of the population and of incident lung cancers would be covered?
    Pinsky PF; Berg CD
    J Med Screen; 2012 Sep; 19(3):154-6. PubMed ID: 23060474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benefits and Challenges of Lung Cancer Screening in Older Adults.
    Fabrikant MS; Wisnivesky JP; Marron T; Taioli E; Veluswamy RR
    Clin Ther; 2018 Apr; 40(4):526-534. PubMed ID: 29573852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Personalizing annual lung cancer screening for patients with chronic obstructive pulmonary disease: A decision analysis.
    Lowry KP; Gazelle GS; Gilmore ME; Johanson C; Munshi V; Choi SE; Tramontano AC; Kong CY; McMahon PM
    Cancer; 2015 May; 121(10):1556-62. PubMed ID: 25652107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Economic impact of lung cancer screening in France: A modeling study].
    Gendarme S; Perrot É; Reskot F; Bhoowabul V; Fourre G; Souquet PJ; Milleron B; Couraud S
    Rev Mal Respir; 2017 Sep; 34(7):717-728. PubMed ID: 26585377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lung cancer screening with low-dose computed tomography: Experiences from a tertiary hospital in Taiwan.
    Chen CY; Chen CH; Shen TC; Cheng WC; Hsu CN; Liao CH; Chen CY; Hsia TC; Liao WC; Tu CY; Shih CM; Hsu WH
    J Formos Med Assoc; 2016 Mar; 115(3):163-70. PubMed ID: 26714425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying high risk individuals for targeted lung cancer screening: Independent validation of the PLCO
    Weber M; Yap S; Goldsbury D; Manners D; Tammemagi M; Marshall H; Brims F; McWilliams A; Fong K; Kang YJ; Caruana M; Banks E; Canfell K
    Int J Cancer; 2017 Jul; 141(2):242-253. PubMed ID: 28249359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.